Cancer Vaccine

Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program

Moderna

COVID-19 Vaccine Funding

Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for COVID-19 Vaccine

Moderna

COVID-19 Vaccine

Moderna Begins Phase 3 COVE Study of mRNA Vaccine Against COVID-19

Moderna

COVID-19 Vaccine

Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

Moderna

Vaccine Collaboration

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

Moderna

Moderna Highlights Opportunity of mRNA Vaccines

Moderna

Coronavirus

Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus

Moderna

Positive Results

Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)

Moderna

Vaccines

Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains

Moderna

Award

DPS Group and TRIA Congratulate Moderna on ISPE 2019 Facility of the Future Category Award

Arcadis